Dr. Yasaman Aghazadeh, Canada
Recapitulating the vascular niche to improve beta cell replacement therapies for T1D

William Rust, United States
Stem cell-derived islets for treating diabetes: The Seraxis approach

Jerome Ritz, United States
Planning for clinical trials: Lessons learned from autologous iPSC-derived products

Tom Bollenbach, United States
Scale - up manufacturing; how to do it or not so easy?

James Markmann, United States
Panel Discussion and Q&A